Version française  |     | 
Print this page | Send this page

Laboratoire de Biologie Moléculaire et Cellulaire du Cancer

  • Activities
  • RDI


Context box end
Contact

Laboratoire de Biologie Moléculaire et Cellulaire du Cancer

Hôpital Kirchberg, 9 rue Steichen; L-2540; Luxembourg; LUXEMBOURG
Luxembourg

Phone: +352 24 68 40 40
Fax: +352 24 68 40 60
E-mail: marc.diederich@lbmcc.lu

Website:


Staff number : 10-49

Description of activities

The LBMCC is a laboratory of fundamental research. It is interested in:

  • molecular mechanisms implicated in the development of resistances against chemotherapeutic agents;
  • the differentiation therapy based on an approach where malignant cells are treated in a way that these more immature cells may differentiate into more mature cells;
  • the development of novel therapeutic approaches based on compounds of natural origin.

The LBMCC is involved in two European projects:

  • CORENA-Network; to promote the use of natural products and to form a network between researchers, the industry and Universities. Website: www.corena-network.eu
  • RedCat-Network; an initial training network for experienced and early stage researchers. Website: www.redcat-network.eu

Products and services

As a service provider, we collaborate with different chemist groups or companies in order to quantify specific natural compounds or assess biological effects of extracts or purified compounds regarding cell death and inflammation mechanisms. We have the ability to test and/or screen for any kind of natural or synthetic compounds. For the moment we are assessing the effect various garlic and curcumin compounds and different compounds from marine and plant origins. They are all tested for their potential anti-cancer and anti-inflammatory properties.

Trading area

International

International locations

Greater Region

Additional information

The LBMCC is co-financed by the association "Recherche Scientifiques Luxembourg", by the fundation "Fondation de Recherche Cancer et Sang", and by the Télévie.

The LBMCC also receives financial support from "Een Haerz fir Kriibskrank Kanner" and the Ministry of Research.